This was the stock's second consecutive day of losses.
Taking place on Saturday 8 March, 2025 at Lindley Hall in London, British Watchmakers’ Day is a key event in the horological ...
AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...
The Investment Committee give you their top stocks to watch for the second half.
AbbVie, Vertex Pharmaceuticals, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to ...
The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Investor's Business Daily on MSN7d
Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid PainkillerVertex Pharmaceuticals won FDA approval for its non-opioid painkiller Journavx. Vertex stock jumped in late trading.
The initial concept to focus on pain-signaling proteins came out of research involving people with a rare hereditary ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback